+65 3158 9910
1300 798 820
+64 9801 0299
Singapore, 29 March 2022: A NEW drug shown to significantly reduce the risk of cancer recurrence or death in an aggressive form of breast cancer is now available in Malaysia. The drug, NERLYNX® (neratinib) is an oral medication taken for 12 months by women who have been diagnosed with early stage HER2-positive (HER2+) breast cancer and who have received prior trastuzumab-based therapy.
The following tweet and story appeared on 7NEWS November 2021. A new treatment is now within reach for sufferers of a rare and incurable cancer. The new tablet has been listed on the PBS, helping buy patients precious time. Click here to watch: https://youtu.be/bPUTlbcamVo @AKunowski #7NEWS
QINLOCK® (ripretinib) now PBS listed for Australian patients QINLOCK is the first new reimbursed therapy to treat advanced GIST in more than a decade Leading Australian oncologist says the listing will help to “buy patients more time” Data shows QINLOCK reduces risk of disease progression by 85%1, 2 14 November, 2021: AUSTRALIAN cancer patients